Shares of Sarepta Therapeutics Inc (NASDAQ:SRPT) plunged 10% after the company disclosed that the U.S. Food and Drug ...

Sarepta Therapeutics (SRPT) shares fell as much as 4.8% in premarket trading Monday, poised to extend losses for a second ...

Sarepta Therapeutics faces challenges as the FDA halts gene therapy trials for LGMD and revokes AAVrh74 platform designation.

Investors in Sarepta Therapeutics Inc (Symbol: SRPT) saw new options become available today, for the July 25th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ...

Investors in Sarepta Therapeutics Inc (Symbol: SRPT) saw new options become available today, for the July 3rd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ...

SRPT stock has cleared six out of the eight parameters to achieve a "Perfect 10" Smart Score. ... XPO Logistics and Sarepta Therapeutics (NASDAQ:SRPT). But before moving ahead, let’s ...

Investors in Sarepta Therapeutics Inc (Symbol: SRPT) saw new options begin trading today, for the June 2023 expiration. One of the key inputs that goes into the price an option buyer is willing to ...

Investors in Sarepta Therapeutics Inc (Symbol: SRPT) saw new options begin trading today, for the August 2025 expiration. One of the key inputs that goes into the price an option buyer is willing ...

Below is Validea's guru fundamental report for SAREPTA THERAPEUTICS INC (SRPT). Of the 22 guru strategies we follow, SRPT rates highest using our P/B Growth Investor model based on the published ...

Below is Validea's guru fundamental report for SAREPTA THERAPEUTICS INC (SRPT). Of the 22 guru strategies we follow, SRPT rates highest using our P/B Growth Investor model based on the published ...

Investors in Sarepta Therapeutics Inc (Symbol: SRPT) saw new options become available today, for the June 2024 expiration. One of the key data points that goes into the price an option buyer is ...